April 29, 2015. Many patients with higher-risk localized prostate cancer are treated with external beam radiation or with brachytherapy (seed implants). A clinical trial conducted by Dr James Miller (right) of Vancouver, Canada has found that patients receiving permanent implant brachytherapy “seeds” plus a boost of radiation have a better chance of long-term survival than those treated with higher dose-escalated external beam radiotherapy but without the implants.
Men receiving the radioactive “seeds” were more likely to be cancer-free five to nine years later. Continue reading “Brachytherapy combination improves PSA-free Survival for patients with higher-risk localized prostate cancer, trial finds”